Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study

Lancet

Volumn 353, Issue 9170, 1999, Pages 2111-2115

  Franklyn, Jayne A ^a   Maisonneuve, Patrick ^b   Sheppard, Michael ^a   Betteridge, Joan ^a   Boyle, Peter ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ARTICLE; BIOSTATISTICS; BLADDER CANCER; BRONCHUS CANCER; CANCER INCIDENCE; CANCER MORTALITY; COHORT ANALYSIS; FEMALE; HUMAN; HYPERTHYROIDISM; LEUKEMIA; LYMPHATIC SYSTEM TUMOR; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; TRACHEA CANCER; UNITED KINGDOM;

EID: 0033583978     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)12295-X     Document Type: Article

References (26)

1. Franklyn J.A. The management of hyperthyroidism. N Engl J Med. 330:1994;1731-1738.
2. Baxter M., Stewart P.M., Daykin J., Sheppard M.C., Franklyn J.A. Radioiodine therapy in young patients: perception of risk and use. QJM. 86:1993;495-499.
3. Baverstock K., Egloff B., Pinchera A., Ruchti C., Williams D. Thyroid cancer after Chernobyl. Nature. 359:1992;21-22.
4. Pacini F., Vorontsova T., Demidchik E.P.et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab. 82:1997;3563-3569.
5. Hall P., Boice J.D. Jr., Berg G.et al. Leukaemia incidence after iodine-131 exposure. Lancet. 340:1992;1-4.
6. Holm L.E, Hall P., Wiklund K.et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst. 83:1991;1072-1077.
7. Hoffman D.A., McConahey W.M., Fraumeni J.F., Kurland L.T. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol. 11:1982;218-224.
8. Hoffman D.A., McConahey W.M., Diamond E.L., Kurland L.T. Mortality in women treated for hyperthyroidism. Am J Epidemiol. 115:1982;243-254.
9. Hoffman D.A., McConahey W.M. Breast cancer following iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst. 70:1983;63-67.
10. Hall P., Berg G., Bjelkengren G.et al. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer. 50:1992;886-890.
11. Ron E., Doody M.M., Becker D.V.et al. Cancer mortality following treatment for adult hyperthyroidism. JAMA. 280:1998;347-355.
12. Barber S.G., Carter D.J., Bishop J.M. System for long-term review of patients at risk of becoming hypothyroid: further experience. Lancet. ii:1977;967-970.
13. Franklyn J.A., Daykin J., Drolc Z., Farmer M., Sheppard M. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf). 34:1991;71-77.
14. International classification of diseases: manual of the international classification of diseases, injuries, and causes of death, 9th rev, vol 1. Geneva: World Health Organization, 1977.
15. Waterhouse J, Muir CS, Shanmugaratnam K, Powell J, eds. Cancer incidence in five continents, vol III. IARC scientific publication no 15. Lyon: IARC, 1976.
16. Waterhouse J, Muir CS, Shanmugaratnam K, Powell J, eds. Cancer incidence in five continents, vol IV. IARC scientific publication no 42. Lyon: IARC, 1982.
17. Muir CS, Waterhouse J, Mack T, Powell J, Whelan SL, eds. Cancer incidence in five continents, vol V. IARC scientific publication no 88. Lyon: IARC, 1987.
18. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer incidence in five continents, vol VI. IARC scientific publication no 120. Lyon: IARC, 1992.
19. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer incidence in five continents, vol VII. IARC scientific publication no 143. Lyon: IARC, 1997.
20. Franklyn J.A., Maisonneuve P., Sheppard M.C., Betteridge J., Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med. 338:1998;712-718.
21. Goldman M.B., Maloof F., Monson R.R., Aschengrau A., Cooper D.S., Ridgway E.C. Radioactive iodine therapy and breast cancer. Am J Epidemiol. 127:1988;969-980.
22. Boyle P. Cancer, cigarette smoking and premature death in Europe: a review including the recommendations of European cancer experts consensus meeting, Helsinki October 1996. Lung Cancer. 17:1997;1-60.
23. Dobyns B.M., Sheline G.E., Workman J.B., Tompkins E.A., McConahey W.M., Becker D.V. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab. 38:1974;976-998.
24. Thompson D.E., Mabuchi K., Ron E.et al. Cancer incidence in atomic bomb survivors, part II: solid tumors, 1958-1987. Radiat Res. 137(2):1994;17-67.
25. Shore R.E., Woodard E., Hildreth N., Dvoretsky P., Hempelmann L., Pasternack B. Thyroid tumors following thyroid irradiation. J Natl Cancer Inst. 74:1985;1177-1184.
26. Kerber R.A., Till J.E., Simon S.L.et al. A cohort study of thyroid disease in relation to fall-out from nuclear weapons testing. JAMA. 270:1993;2076-2082.